251 related articles for article (PubMed ID: 6615058)
21. Prognosis of thick cutaneous melanoma of the trunk and extremity.
Coit D; Sauven P; Brennan M
Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
24. Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Melanoma Res; 1995 Jun; 5(3):189-94. PubMed ID: 7640521
[TBL] [Abstract][Full Text] [Related]
25. Elective regional lymph node dissection in malignant melanoma.
Binder M; Pehamberger H; Steiner A; Wolff K
Eur J Cancer; 1990; 26(8):871-3. PubMed ID: 2145927
[TBL] [Abstract][Full Text] [Related]
26. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
27. Management of patients with intermediate-thickness melanoma.
Urist MM
Annu Rev Med; 1996; 47():211-7. PubMed ID: 8712776
[TBL] [Abstract][Full Text] [Related]
28. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
29. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
30. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
31. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma.
Kretschmer L; Preusser KP; Marsch WC; Neumann C
Melanoma Res; 2000 Oct; 10(5):483-9. PubMed ID: 11095410
[TBL] [Abstract][Full Text] [Related]
33. Elective lymph node dissection in stage I melanoma--necessary or not?
Adams CM; Giltman LI
Am Surg; 1985 Sep; 51(9):504-7. PubMed ID: 3898948
[TBL] [Abstract][Full Text] [Related]
34. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
35. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
Mills JK; White I; Diggs B; Fortino J; Vetto JT
Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
[TBL] [Abstract][Full Text] [Related]
36. Elective lymph node dissection in stage I malignant melanoma: a meta-analysis.
Hein DW; Moy RL
Melanoma Res; 1992 Nov; 2(4):273-7. PubMed ID: 1490115
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
38. Primary Dermal Melanoma (PDM): Histological and Clinical Interdependence to Guide Therapy.
Zamir H; Feinmesser M; Gutman H
J Cutan Med Surg; 2021; 25(1):53-58. PubMed ID: 32912013
[TBL] [Abstract][Full Text] [Related]
39. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
40. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
